Published in Br J Cancer on June 01, 1983
The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer (1988) 3.07
Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed) (1986) 2.08
Long term effects of childbearing on health. J Epidemiol Community Health (1985) 2.05
Risk factors for self-reported uterine fibroids: a case-control study. Am J Public Health (1996) 1.36
The epidemiology of endometrial and ovarian cancer. Hematol Oncol Clin North Am (2011) 1.34
The effects of moderate physical activity on menstrual cycle patterns in adolescence: implications for breast cancer prevention. Br J Cancer (1987) 1.27
Reproductive risk factors for endometrial cancer among Polish women. Br J Cancer (2007) 1.20
Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use. Br J Cancer (1995) 1.02
Reproductive history, socioeconomic status, and self-reported health status of women aged 50 years or older. Am J Public Health (1997) 1.00
Molecular pathogenesis of endometrial and ovarian cancer. Cancer Biomark (2010) 0.95
Genome-wide association study of endometrial cancer in E2C2. Hum Genet (2013) 0.93
Induced abortion as cancer risk factor: a review of epidemiological evidence. J Epidemiol Community Health (1990) 0.87
Prospective evaluation of insulin resistance among endometrial cancer patients. Am J Obstet Gynecol (2011) 0.86
A cohort analysis of breast cancer, uterine corpus cancer, and childbearing pattern in Norwegian women. J Epidemiol Community Health (1990) 0.84
Exogenous hormones in the aetiology of cancer in women. J R Soc Med (1984) 0.81
Childhood body mass index and height and risk of histologic subtypes of endometrial cancer. Int J Obes (Lond) (2016) 0.78
Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence. Clin Interv Aging (2008) 0.76
Endometrial carcinoma in a young woman. Arch Gynecol Obstet (1988) 0.75
Estrogen replacement therapy (ERT) in high-risk cancer patients. Yale J Biol Med (1992) 0.75
On the age-dependent association between cancer of the breast and endometrium. Br J Cancer (1987) 0.75
Hormone replacement therapy and breast cancer, endometrial cancer and cardiovascular disease: risks and benefits. Br J Gen Pract (1992) 0.75
Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2). Br J Cancer (2015) 0.75
[The role of progestins]. Arch Gynecol Obstet (1989) 0.75
Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med (1975) 5.33
Estimation of multiple relative risk functions in matched case-control studies. Am J Epidemiol (1978) 4.76
Association of exogenous estrogen and endometrial carcinoma. N Engl J Med (1975) 3.89
Estrogens and endometrial cancer in a retirement community. N Engl J Med (1976) 3.64
Endogenous hormones as a major factor in human cancer. Cancer Res (1982) 3.30
Multivariate analysis for matched case-control studies. Am J Epidemiol (1978) 2.40
Cancer surveillance program in Los Angeles County. Natl Cancer Inst Monogr (1977) 2.21
Oestrogens and obesity as risk factors for endometrial cancer in Italy. Int J Epidemiol (1982) 1.64
Epidemiology of endometrial cancer. J Natl Cancer Inst (1977) 1.50
A case-control study of cancer of the endometrium. Am J Epidemiol (1982) 1.50
An epidemiological investigation of cancer of the endometrium. Cancer (1966) 1.32
Endometrial hyperplasia, endometrial carcinoma, and endometriosis produced experimentally by estrogen. Cancer (1958) 1.30
Carcinoma of the corpus uteri in young women. Am J Obstet Gynecol (1951) 1.28
Steroid hormones and endometrial cancer. Cancer Res (1978) 1.28
Exogenous estrogen and endometrial carcinoma: case-control and incidence study. Am J Obstet Gynecol (1977) 1.28
Serum sex hormone-binding globulin capacity and the percentage of free estradiol in postmenopausal women with and without endometrial carcinoma. A new biochemical basis for the association between obesity and endometrial carcinoma. Am J Obstet Gynecol (1980) 1.19
Progesterone antagonism of the oestrogen receptor and oestrogen-induced uterine growth. Nature (1975) 1.18
Sex hormone concentrations in post-menopausal women. Clin Endocrinol (Oxf) (1978) 1.11
Induction of human endometrial estradiol dehydrogenase by progestins. Endocrinology (1975) 1.11
Decreased risk of endometrial cancer among oral-contraceptive users. N Engl J Med (1980) 1.11
Endometrial carcinoma in young women taking oral contraceptive agents. Obstet Gynecol (1975) 1.09
Incidence of endometrial cancer in relation to the use of oral contraceptives. N Engl J Med (1980) 1.08
Protection against endometrial carcinoma by combination-product oral contraceptives. JAMA (1982) 1.00
Genesis of endometrial carcinoma; cases 19 to 35 years old. Cancer (1949) 0.95
Endometrial carcinoma in young women. A clinical profile. Obstet Gynecol (1968) 0.93
Host factors in cancer of the breast and uterine cervix and corpus. J Natl Cancer Inst (1960) 0.90
The development of adenocarcinoma of the endometrium in young women receiving long-term sequential oral contraception. Am J Obstet Gynecol (1975) 0.79
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer (1976) 22.55
Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics (1973) 18.14
A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol (2000) 13.17
Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1977) 5.87
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst (1993) 5.07
Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst (2000) 4.93
A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev (1994) 4.62
Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles. Am J Epidemiol (2000) 4.46
Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet (1983) 4.38
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet (1992) 4.11
Morbidity and mortality in relation to cigarette smoking in Shanghai, China. A prospective male cohort study. JAMA (1996) 3.77
Estrogens and endometrial cancer in a retirement community. N Engl J Med (1976) 3.64
'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature (1983) 3.63
A spontaneous lower motor neuron disease apparently caused by indigenous type-C RNA virus in wild mice. J Natl Cancer Inst (1973) 3.59
Undescended testis: the effect of treatment on subsequent risk of subfertility and malignancy. J Pediatr Surg (1986) 3.54
Apparent doubling of frequency of undescended testis in England and Wales in 1962-81. Lancet (1984) 3.54
Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Trans R Soc Trop Med Hyg (1972) 3.44
Risk factors for cancer of the testis in young men. Int J Cancer (1979) 3.42
Increased cell division as a cause of human cancer. Cancer Res (1990) 3.38
Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst (1999) 3.35
Treatment of zoster with idoxuridine in dimethyl sulphoxide. Results of two double-blind controlled trials. Br Med J (1970) 3.30
Endogenous hormones as a major factor in human cancer. Cancer Res (1982) 3.30
Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer (1991) 3.14
Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br J Cancer (1992) 3.10
The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer (1988) 3.07
Trends in mortality among British doctors in relation to their smoking habits. J R Coll Physicians Lond (1972) 2.99
Statistical analysis of patient-control studies in epidemiology. Factor under investigation an all-or-none variable. Br J Prev Soc Med (1970) 2.94
Physical exercise and reduced risk of breast cancer in young women. J Natl Cancer Inst (1994) 2.93
The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol (1988) 2.91
Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer (1981) 2.89
Aspirin use and chronic diseases: a cohort study of the elderly. BMJ (1989) 2.89
A method of analysis of a certain class of experiments in carcinogenesis. Biometrics (1966) 2.86
Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med (1995) 2.83
Risk of testicular cancer in cohort of boys with cryptorchidism. BMJ (1997) 2.71
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet (1993) 2.58
Cancer incidence in the Mexican-American. J Natl Cancer Inst (1975) 2.54
Geographical variation in mortality from leukaemia and other cancers in England and Wales in relation to proximity to nuclear installations, 1969-78. Br J Cancer (1989) 2.50
The long-term prognosis of severe infantile malnutrition. Lancet (1967) 2.44
Burkitt's tumour in the West Nile District Uganda, 1961-5. Br Med J (1967) 2.43
Toward the primary prevention of cancer. Science (1991) 2.41
Descriptive epidemiology of testicular and prostatic cancer in Los Angeles. Br J Cancer (1979) 2.39
Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res (1989) 2.35
Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst (1983) 2.34
A multipurpose serological survey in Kenya. 2. Results of arbovirus serological tests. Bull World Health Organ (1970) 2.34
An improved approximate formula for calculating sample sizes for comparing two binomial distributions. Biometrics (1978) 2.32
A prospective study of pancreatic cancer in the elderly. Int J Cancer (1994) 2.25
Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst (1990) 2.23
Epidemiology of soy exposures and breast cancer risk. Br J Cancer (2008) 2.22
Occupational differences in rates of lung cancer. J Occup Med (1976) 2.19
"Incessant ovulation" and ovarian cancer. Lancet (1979) 2.18
A case-control study of menopausal estrogen therapy and breast cancer. JAMA (1980) 2.15
Estrogens and breast cancer. Carcinogenesis (1996) 2.15
An epidemiologic study of breast cancer. J Natl Cancer Inst (1974) 2.15
Menopausal estrogen therapy and hip fractures. Ann Intern Med (1981) 2.13
Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance. J Immunol (1976) 2.11
Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed) (1986) 2.08
Disease clustering: a generalization of Knox's approach to the detection of space-time interactions. Biometrics (1968) 2.06
The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors. J Neurosci (1999) 2.06
Stroke prevention and oestrogen replacement therapy. Lancet (1989) 2.05
Follow up study of moderate alcohol intake and mortality among middle aged men in Shanghai, China. BMJ (1997) 2.05
The growing importance of California arboviruses in the etiology of human disease. Prog Med Virol (1971) 2.04
The question of estrogen replacement therapy in patients with a prior diagnosis of breast cancer. Oncology (Williston Park) (1990) 2.04
Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol (1995) 2.02
A controlled trial of the treatment of Mycobacterium ulcerans infection with clofazimine. Lancet (1973) 2.02
Chemoattractant receptors on phagocytic cells. Annu Rev Immunol (1984) 2.01
Urogenital tract abnormalities in sons of women treated with diethylstilbestrol. Pediatrics (1976) 2.00
Smoking, air pollution, and the high rates of lung cancer in Shenyang, China. J Natl Cancer Inst (1989) 1.99
Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. IARC Monogr Eval Carcinog Risk Chem Hum Suppl (1980) 1.99
Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Cancer Res (1986) 1.98
Yellow fever immunity surveys in northern Uganda and Kenya and eastern Somalia, 1966-67. Bull World Health Organ (1968) 1.96
Exercise and other factors in the prevention of hip fracture: the Leisure World study. Epidemiology (1991) 1.96